In re Abbott Laboratories Norvir Antitrust Litigation
Settlement Information Website

WELCOME TO THE NORVIR ANTITRUST LITIGATION WEBSITE


Si habla español, presione aquí

There is a proposed class action Settlement with Abbott Laboratories ("Abbott") involving the drug Norvir. The lawsuit is called In re Abbott Laboratories Norvir Antitrust Litigation, Docket No. 04-CV-1511-CW, pending in the U.S. District Court for the Northern District of California. The Class Action alleges that Abbott Laboratories ("Abbott" or "Defendant") unlawfully raised the price of its prescription drug Norvir to restrict competition. Norvir is the brand name for ritonavir and is a drug manufactured by Abbott. Norvir is used to treat HIV and AIDS. Abbott denies the claims asserted in the lawsuit.

The Class Action seeks money damages and injunctive relief for: a) those consumers who purchased Norvir as a booster to other protease inhibitors, and b) those Third-Party Payors, such as health plans or insurance companies, that paid for Norvir from December 3, 2003 to July 30, 2008 (the “Class”). The consumers are called “Individual Class Members” and the Third-Party Payors are called “Institutional Class Members.” Collectively, Individual Class Members and Institutional Class Members are “Class Members”.

Summary of Your Rights and Choices:


You May: Due Date:
Remain In The Class And File A Registration Form Remain a Class Member

Stay in the Lawsuit and Wait for the Result.


By doing nothing, you remain a Class Member, stay in the lawsuit, and will be bound by the Settlement. By remaining in the Class, you give up your right to sue Abbott on your own behalf about the claims in the lawsuit. You will also be bound by the outcome of any trial if the Court does not approve the Settlement and the case proceeds instead to trial.

If Abbott does not fully prevail on its appeal and therefore pays either $14.375 million or $27.5 million AND you are: a) an Individual Class Member residing in California, or b) an Institutional Class Member who has paid for Norvir on behalf of patients residing in California, you may share in the payment as described in further detail below. In order to be eligible for a share in the payment you must submit a Registration Form postmarked by July 24, 2009.
To Remain In The Class Do Nothing


To Be Eligible to Make A Claim, Submit A Registration Form Postmarked By July 24, 2009
Or

File Online By
July 24, 2009
EXCLUDE YOURSELF Get Out Of The Class.

You can exclude yourself from the Class by writing and asking to be excluded. If you exclude yourself, you will not get any payment from this Settlement. But, you may be able to sue Abbott on your own on the claims at issue in the lawsuit.

For more information, please read the full Notice.
Postmarked By July 24, 2009
Remain In The Class But Object To The Settlement Remain In The Class But Object To The Settlement.

If you do not exclude yourself, you can remain in the Class, but at the same time object to any aspect of the Settlement.

For more information, please read the full Notice.
Objection Must Be Postmarked by July 24, 2009